Bill

Bill > S2741


NJ S2741

Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.


summary

Introduced
02/15/2024
In Committee
02/15/2024
Crossed Over
Passed
Dead

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill prohibits the sale of certain items which use advertisements linked or alluding to controlled dangerous substances or analogs. The bill bans the sale of any food, beverage, or other product meant to be ingested or inhaled which uses the advertisement on its packaging or elsewhere. The bill further prohibits the sale of any product using the advertising, regardless of the product's intended use, to a person under 18 years of age. The bill specifies that the provisions do not apply to any prescription medication dispensed by a pharmacist pursuant to a valid prescription. A violation under the bill would be an unlawful practice under the consumer fraud act, which is punishable by a monetary penalty of not more than $10,000 for a first offense and not more than $20,000 for any subsequent offense. Additionally, a violation can result in a cease and desist order issued by the Attorney General, the assessment of punitive damages, and the awarding of treble damages and costs to the injured.

AI Summary

This bill prohibits the sale of any food, beverage, or other ingestible or inhalable product, as well as any other product sold to a person under 18 years of age, that uses advertising linking or alluding to controlled dangerous substances or their analogs. The bill specifies that this prohibition does not apply to prescription medications dispensed by a pharmacist pursuant to a valid prescription. Violations would be considered an unlawful practice under the consumer fraud act, punishable by monetary penalties, cease and desist orders, and the potential for treble damages and costs.

Committee Categories

Justice

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Law and Public Safety Committee (on 02/15/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...